Human pharmacogenetics: Introduction
Weinshilboum, R.M.
Federation Proceedings 43(8): 2295-2297
1984
ISSN/ISBN: 0014-9446 PMID: 6714435 Document Number: 232077
Document emailed within 1 workday
Related Documents
Weber, W.W. 1984: Acetylation pharmacogenetics: experimental models for human toxicity Federation Proceedings 43(8): 2332-2337Woodson, L.C.; Dunnette, J.H.; Weinshilboum, R.M. 1982: Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies Journal of Pharmacology and Experimental Therapeutics 222(1): 174-181
Coutin, R. 1998: Introduction of pests and introduction or risk of introduction of injuriousness organisms: information published on these subjects in Phytoma-LdV Phytoma (Paris) 506: 24-26
Coutin, R. 1998: Introduction of pests and introduction or risk of introduction of injuriousness organisms: information published on these subjects in Phytoma-LdV Phytoma (Paris) 506: 24-26
Coutin, R. 1998: Introduction of pests and introduction or risk of introduction of injuriousness organisms: information published on these subjects in Phytoma-LdV Phytoma (Paris) 506: 24-26
Coutin, R. 1998: Introduction of pests and introduction or risk of introduction of injuriousness organisms: information published on these subjects in Phytoma-LdV Phytoma (Paris) 506: 24-26
Coutin, R. 1998: Introduction of pests and introduction or risk of introduction of injuriousness organisms: information published on these subjects in Phytoma-LdV Phytoma (Paris) 506: 24-26
Coutin, R. 1998: Introduction of pests and introduction or risk of introduction of injuriousness organisms: information published on these subjects in Phytoma-LdV Phytoma (Paris) 506: 24-26
Murakami, Y.S.; Albertsen, H.; Brothman, A.R.; Leach, R.J.; White, R.L. 1996: Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10 Cancer Research 56(9): 2157-2160
Lamy, M. 1972: Pharmacogenetics La Nouvelle Presse Medicale 1(46): 3103-3106
Jörgensen, G. 1979: What is pharmacogenetics? Therapie der Gegenwart 118(5): 699
Rodríguez-Nóvoa, S.; Barreiro, P.; Jiménez-Nacher, I.; Rendón, A.; Soriano, V. 2005: Pharmacogenetics in HIV therapy Aids Reviews 7(2): 103-112
Smith, M.W.; Mendoza, R.P. 1996: Ethnicity and pharmacogenetics Mount Sinai Journal of Medicine new York 63(5-6): 285-290
Brinker, R.R.; Ranganathan, P. 2010: Methotrexate pharmacogenetics in rheumatoid arthritis Clinical and Experimental Rheumatology 28(5 Suppl 61: S33-S39
Furukori, N. 2010: Clinical pharmacogenetics in the treatment of schizophrenia Nihon Shinkei Seishin Yakurigaku Zasshi 30(2): 65-69
Schroner, Z.; Javorsky, M.; Kozarova, M.; Tkac, I. 2011: Pharmacogenetics of oral antidiabetic treatment Bratislavske Lekarske Listy 112(8): 441-446
Juli, G.; Juli, L. 2016: Pharmacogenetics: does a personal therapy exist? Psychiatria Danubina 28(Suppl-1): 141-144
Blardi, P. 1997: Pharmacogenetics: pharmacokinetics and clinical implications Recenti Progressi in Medicina 88(1): 46-55
Lanfear, D.E.; McLeod, H.L. 2007: Pharmacogenetics: using DNA to optimize drug therapy American Family Physician 76(8): 1179-1182
Gachályi, B.; Róna, K.; Vas, A. 1990: Phenocopy and pharmacogenetics. An issue for controversy? International Journal of Clinical Pharmacology Therapy and Toxicology 28(11): 490